Metabolic Research Peptide

Cagrilintide

Size: 10MG

Select product size
Cagrilintide GREYLINE research vial
$139.982 vials · $69.99 per vial
Select quantity tier
2
VisaDiscoverMastercardAmerican ExpressApple PayBitcoin

For research use only. Not for human or veterinary use.

Product Description

Cagrilintide is an investigational, long-acting, acylated amylin analog designed for once-weekly exposure in clinical development. It engages amylin-receptor pathways and has been studied alone and with semaglutide in randomized human trials, but it is not an FDA-approved drug and should not be described as established therapy. The catalog artwork names cagrilintide and 10 mg, while omitting the salt and formulation; chemical values below therefore describe the active-moiety database record, not a confirmed vial composition.

Certificate of Analysis

Lot-specific analytical results and downloadable documentation

Compound Information

Technical specifications

Molecular Profile

What is Cagrilintide?

Type
Long-acting acylated amylin analog peptide
CAS number
1415456-99-3
Molecular weight
4409 g/mol
Amino acids
37-residue amylin-derived peptide plus an N-terminal modifying group
Molecular formula
C194H312N54O59S2
PubChem: Cagrilintide
Storage Requirements

Stability Information

Formulation-specific stability unknownKeep sealed and dryProtect from light
Lyophilized / unopenedNo product-specific shelf life supplied; follow a qualified laboratory SOP.
Reconstituted / in solutionNo authoritative hold time supplied; use a validated laboratory protocol.

No formulation-specific stability package was supplied for this 10 mg catalog material.

Sources & References

Peer-reviewed and authoritative records

Journal of Medicinal Chemistry

Primary research

Development of Cagrilintide, a Long-Acting Amylin Analogue

Kruse T, Hansen JL, Dahl K, et al.

View Source

The Lancet

Primary research

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

Lau DCW, Erichsen L, Francisco AM, et al.

View Source

ClinicalTrials.gov

Clinical trial registry

Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity (NCT03856047)

Novo Nordisk A/S

View Source

Important Research Notice

Not for human consumption. This product is sold exclusively for laboratory, analytical, and educational research purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

Research information presented on this page is provided for educational reference and should not be interpreted as medical advice or as a product claim.

By purchasing this product, the customer confirms that it will be handled and used only by qualified individuals in accordance with all applicable laws and laboratory procedures.

Premium research peptides,
refined for modern researchers.

High purity. Verified quality. Trusted by researchers worldwide.

Shop Now